مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,022
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

FREQUENCY OF ANTI-TOXOPLASMA IGM AND IGG ANTIBODIES IN LEUKEMIC PATIENTS

Pages

  217-222

Abstract

 Aim: the efficacy and safety of combined therapy with ANTICHOLINERGICS and ALPHA BLOCKERS in comparison with ALPHA BLOCKERS monotherapy among patients with BPH.Methods: We conducted a single blinded RCT and 80 patients with BPH who referred to Ali-ebn-abitaleb, Zahedan were included. One group received 0.4 mg/d Tamsulosin in addition to Tolterodine and the other group received the same doses of Tamsulosin in addition to placebo. Both groups were evaluated before and 6 months after treatment with special attention to clinical symptoms, life quality improvement and treatment satisfaction. SPSS was applied for data analysis.Results: There is no significant difference between these two groups of patients’ demographics and basic indices such as PVR, PSA and the volume of prostate. IPSS was significantly improved among patients who received Toltrodine (p=0.0008) whereas both groups showed same score before treatment.Conclusion: It seems that combined therapy with ANTICHOLINERGICS and ALPHA BLOCKERS is a safe and efficient regimen among patients with BPH, either as primary or alternative treatment after the failure of conventional treatments.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    GHARAVI, M.J., ROOZBEHANI, M., & MANDEH, Z.. (2015). FREQUENCY OF ANTI-TOXOPLASMA IGM AND IGG ANTIBODIES IN LEUKEMIC PATIENTS. ALBORZ UNIVERSITY MEDICAL JOURNAL, 4(4), 217-222. SID. https://sid.ir/paper/254364/en

    Vancouver: Copy

    GHARAVI M.J., ROOZBEHANI M., MANDEH Z.. FREQUENCY OF ANTI-TOXOPLASMA IGM AND IGG ANTIBODIES IN LEUKEMIC PATIENTS. ALBORZ UNIVERSITY MEDICAL JOURNAL[Internet]. 2015;4(4):217-222. Available from: https://sid.ir/paper/254364/en

    IEEE: Copy

    M.J. GHARAVI, M. ROOZBEHANI, and Z. MANDEH, “FREQUENCY OF ANTI-TOXOPLASMA IGM AND IGG ANTIBODIES IN LEUKEMIC PATIENTS,” ALBORZ UNIVERSITY MEDICAL JOURNAL, vol. 4, no. 4, pp. 217–222, 2015, [Online]. Available: https://sid.ir/paper/254364/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button